Associate Professor, Biomedical Engineering
Division of General and Gastrointestinal Surgery
Daniel.Gallegoperez@osumc.edu
614-688-3960
473 W. 12th Ave.
Columbus, OH 43210-1252
614-247-7657
Dr. Gallego-Perez’s research focuses on the development of novel biomedical micro- and nanoscale technologies for fundamental and translational applications. Major areas of emphasis in his lab include regenerative medicine, cell and tissue reprogramming, drug and gene delivery and cancer research.
Dr. Gallego-Perez’s NanoMedicine lab is focused on developing and implementing novel nanotechnologies that can be easily interfaced with living systems at the cellular, tissue, or organ level, to gain more insight into specific pathophysiological processes, or to deliver preventive or corrective therapies to injured or diseased cells, tissues, or organs. Tissue Nano-transfection (TNT), an example of such technologies, is currently being further developed by the Gallego-Perez lab for potential applications in the treatment of diabetes, certain neurological conditions, and cancer.
Education
- PhD: The Ohio State University, 2011
Research Interests
- Nanomedicine
- Cell and tissue reprogramming/plasticity
- Cancer and tumor-associated cell motility
- Non-viral gene therapies
- Micro- and nanomanufacturing
- Lumley Interdisciplinary Research Award, 2017
- William G. Lowrie Department of Chemical and Biomolecular Engineering, Outstanding Post-Doc Award for Research Excellence, 2014
- CWRU Society for Biomaterials – Biomaterials Day, Student Presentation Award, 2010
- Ohio State Biomedical Engineering Conference, Best Presentation in Micro/Nanotechnology, 2009
- Society for Biomaterials Meeting, Student Travel Achievement Recognition, 2009
- Biomedical Engineering Society Meeting, Student Travel Award, 2008
- Ohio State Biomedical Engineering Conference, Best Presentation in Micro/Nanotechnology, 2008
- The 8th New Jersey Symposium on Biomaterials Science, Student Travel Scholarship, 2006
- Hansford D, Schley J, Gallego-Perez D. “Electroosmotic devices for fluid handling” US Patent #61/883,592. 9/27/13.
- Pal D, Gallego-Perez D, Ghatak S, Lee LJ, Sen CK. “compositions and methods for reprogramming somatic cells into induced endothelial cells”. Provisional patent filed (2016).